Cargando…
Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis
OBJECTIVE: Apolipoprotein E (APOE) genotypes are associated with cardiovascular disease (CVD) and lipid levels. In rheumatoid arthritis (RA), an association has been found with disease activity. We examined the associations between APOE genotypes and disease susceptibility and markers of disease sev...
Autores principales: | Maehlen, Marthe T., Provan, Sella A., de Rooy, Diederik P. C., van der Helm - van Mil, Annette H. M., Krabben, Annemarie, Saxne, Tore, Lindqvist, Elisabet, Semb, Anne Grete, Uhlig, Till, van der Heijde, Désirée, Mero, Inger Lise, Olsen, Inge C., Kvien, Tore K., Lie, Benedicte A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629235/ https://www.ncbi.nlm.nih.gov/pubmed/23613766 http://dx.doi.org/10.1371/journal.pone.0060970 |
Ejemplares similares
-
The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab
por: Provan, Sella Aarrestad, et al.
Publicado: (2015) -
Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
por: Dougados, Maxime, et al.
Publicado: (2012) -
The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis
por: Mjaavatten, Maria D, et al.
Publicado: (2010) -
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
por: Knevel, Rachel, et al.
Publicado: (2014) -
Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study
por: Uhlig, Till, et al.
Publicado: (2023)